Home > Term: siplizumab
siplizumab
A monoclonal antibody that is being studied in the treatment of certain lymphoproliferative disorders and psoriasis. Also called MEDI-507.
- Μέρος του λόγου: noun
- Κλάδος/Τομέας: Υγεία
- Category: Cancer treatment
- Company: U.S. HHS
0
Δημιουργός
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
